Penserra Capital Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,548
| Closed | -$253K | – | 1244 |
|
|
2023
Q3 | $253K | Buy |
10,548
+2,793
| +36% | +$67K | 0.01% | 672 |
|
|
2023
Q2 | $247K | Buy |
7,755
+1,405
| +22% | +$44.8K | ﹤0.01% | 723 |
|
|
2023
Q1 | $194K | Buy |
6,350
+80
| +1% | +$2.44K | ﹤0.01% | 701 |
|
|
2022
Q4 | $245K | Sell |
6,270
-3,369
| -35% | -$132K | 0.01% | 642 |
|
|
2022
Q3 | $459K | Buy |
9,639
+6,863
| +247% | +$327K | 0.01% | 448 |
|
|
2022
Q2 | $107K | Buy |
2,776
+1,076
| +63% | +$41.5K | ﹤0.01% | 758 |
|
|
2022
Q1 | $97K | Buy |
+1,700
| New | +$97K | ﹤0.01% | 851 |
|
|
2021
Q4 | – | Sell |
-1,525
| Closed | -$132K | – | 1385 |
|
|
2021
Q3 | $132K | Buy |
1,525
+100
| +7% | +$8.66K | ﹤0.01% | 706 |
|
|
2021
Q2 | $183K | Buy |
1,425
+115
| +9% | +$14.8K | ﹤0.01% | 658 |
|
|
2021
Q1 | $104K | Sell |
1,310
-25
| -2% | -$1.99K | ﹤0.01% | 677 |
|
|
2020
Q4 | $108K | Buy |
+1,335
| New | +$108K | ﹤0.01% | 596 |
|